Global oncology experts gathered in Zurich, Switzerland, on June 27, 2026, for the ETOP IBCSG Partners Foundation ADC Workshop.
The event focused on therapeutic advances in antibody-drug conjugates (ADCs), a targeted cancer treatment that spares healthy tissue.
Lung Cancer Session Highlights
David Planchard, Head of the Thoracic Cancer Group at Gustave Roussy, emphasized the importance of the workshop.
He described it as a must-attend event for discussing ADCs and sharing advances across different cancers and specialties.
A dedicated lung cancer session featured presentations by oncologists Solange Peters and Giannis Mountzios. Their talks generated significant discussion on implementing recent therapeutic updates in thoracic oncology.
Planchard, a professor at the University Paris Saclay, praised the session on social media. He noted the superb quality of the presentations and discussions.
